Continuous glucose monitoring to characterize hyperglycemia during chemotherapy for early stage breast cancer

Ulene, S. R., Wang, S., Cook, J. R., McAuley, F., Wooster, M. E., Faheem, K. F., Varoli, A., McGuinness, J. E., Vasan, N., Trivedi, M. S., Crew, K. D., Harden, E., Law, C., Hershman, D. L., & Accordino, M. K. (2025). Continuous glucose monitoring to characterize hyperglycemia during chemotherapy for early stage breast cancer. Breast Cancer Research and Treatment, 212(3), 511–519. https://doi.org/10.1007/s10549-025-07745-z
Authors:
Sophie R Ulene
Shikun Wang
Joshua R Cook
Fiona McAuley
Margaux E Wooster
Khadija F Faheem
Andrew Varoli
Julia E McGuinness
Neil Vasan
Meghna S Trivedi
Katherine D Crew
Erik Harden
Cynthia Law
Dawn L Hershman
Melissa K Accordino
Affiliated Authors:
Sophie R Ulene
Shikun Wang
Joshua R Cook
Fiona McAuley
Margaux E Wooster
Khadija F Faheem
Andrew Varoli
Julia E McGuinness
Neil Vasan
Meghna S Trivedi
Katherine D Crew
Erik Harden
Cynthia Law
Dawn L Hershman
Melissa K Accordino
Columbia Affiliation:
Subjects:
Breast Neoplasms (MeSH)
Hyperglycemia (MeSH)
Antineoplastic Combined Chemotherapy Protocols (MeSH)
Blood Glucose (MeSH)
Blood Glucose Self-Monitoring (MeSH)
Author Keywords:
chemotherapy
continuous glucose monitoring
diabetes
early-stage breast cancer
hyperglycemia
elink
Publication Type:
Article
Unique ID:
10.1007/s10549-025-07745-z
PMID:
40468140
DOI:
10.1007/s10549-025-07745-z
Journal:
Breast Cancer Research and Treatment
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: